R&D Drug repositioning to bring forgotten assets from shelves to... A problem very rarely spoken about is the treatments that are promising, but are not developed further.
Patients Partner Content The PM Society – Giving Back The PM Society is a not-for-profit organisation with 40 years of Giving Back.
News PM Society announces new Chair for 2024 The PM Society has appointed Dom Marchant, Chief Creative Officer at OPEN Health, as Chair, to succeed co-chairs Caroline Benson of Cuttsy + Cuttsy and Colin Williams from Astellas.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
